PERI Form 144 Reveals Proposed 3,115-Share Sale via Oppenheimer

Rhea-AI Filing Summary

Form 144 notice for Perion Network Ltd. (PERI) shows proposed and recent insider sales of ordinary shares. The filer plans to sell 3,115 ordinary shares through Oppenheimer & Co. with an aggregate market value of $29,904, targeting an approximate sale date of 10/01/2025 on NASDAQ. The securities were acquired as restricted stock units from the issuer on 01/01/2025, with 21,788 units noted as acquired that date. A sale by Eyal Kaplan of 3,115 ordinary shares on 07/01/2025 generated gross proceeds of $33,517.71. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Disclosure includes broker and precise transaction details, enhancing transparency for investors
• Securities originated from restricted stock units, indicating the sale relates to compensation vesting rather than external transfers
• Recent sale and proposed sale sizes are small relative to the 44,825,053 shares outstanding, suggesting limited market impact

Negative

• Insider sales were executed and another sale is proposed, which some investors may view negatively
• Issuer name and filer CIK are not populated in the provided extract, which could indicate incomplete metadata in this excerpt

Insights

Securities Analyst

TL;DR: Insider stock sales and a planned disposal are disclosed; transaction sizes are modest relative to outstanding shares.

The filing reports a proposed sale of 3,115 ordinary shares and a prior sale of the same amount, each small relative to the reported 44,825,053 shares outstanding. The securities originated from restricted stock units granted on 01/01/2025, indicating recent compensation vesting. The filing names Oppenheimer & Co. as broker and lists specific market values and gross proceeds, which helps transparency. Overall, the disclosed transactions are immaterial in size versus total outstanding shares, suggesting limited market impact.

Compliance & Risk Analyst

TL;DR: Form 144 appears to follow procedural disclosure requirements; includes standard certification about material information.

The notice contains the required elements: class of securities, broker details, number of shares, aggregate market value, acquisition details showing restricted stock units, and a recent sale with gross proceeds. The signer represents no undisclosed material adverse information and the form warns about legal penalties for misstatements. Missing in the document are explicit filer CIK and issuer name fields in the provided extract, which should be present in the complete filing record; if absent in the official filing, that would be a compliance gap. Based on available content, procedural compliance appears demonstrated.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	3115	29904.00	44825053	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/01/2025	Restricted Stock Units	From the Issuer			21788	01/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eyal Kaplan 2 Leonardo Da Vinci St. 24th Floor Tel Aviv L3 6473309	Ordinary	07/01/2025	3115	33517.71

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 filed for PERI disclose about the proposed sale?

The notice proposes selling 3,115 ordinary shares through Oppenheimer & Co. with an aggregate market value of $29,904, approx. sale date 10/01/2025 on NASDAQ.

Who acquired the securities and how were they acquired?

The securities were acquired as restricted stock units from the issuer on 01/01/2025, with 21,788 units recorded as acquired that date.

Has the filer completed any recent sales in the past three months?

Yes. The filing shows Eyal Kaplan sold 3,115 ordinary shares on 07/01/2025 for gross proceeds of $33,517.71.

How large are these transactions relative to outstanding shares?

The filing lists 44,825,053 shares outstanding; the 3,115-share transactions are immaterial in percentage terms.

Does the filing state whether any material nonpublic information exists?

The signer represents that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.

Which broker is handling the proposed sale?

The proposed sale lists Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004 as the broker.